Literature DB >> 29288338

Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Stefan Esser1, Larissa Göpfrich1, Kai Bihler1, Eugenia Kress1, Stella Nyamoya2, Simone C Tauber3, Tim Clarner2, Matthias B Stope4, Thomas Pufe1, Markus Kipp5, Lars-Ove Brandenburg6.   

Abstract

Multiple sclerosis (MS) is a chronic degenerative disease of the central nervous system that is characterized by myelin abnormalities, oligodendrocyte pathology, and concomitant glia activation. The factors triggering gliosis and demyelination are currently not well characterized. New findings suggest an important role of the innate immune response in the initiation and progression of active demyelinating lesions. Especially during progressive disease, aberrant glia activation rather than the invasion of peripheral immune cells is accountable for progressive neuronal injury. The innate immune response can be induced by pathogen-associated or danger-associated molecular patterns, which are identified by pattern recognition receptors (PRRs), including the Toll-like receptors (TLRs). In this study, we used the cuprizone model in mice to investigate the expression of TLR2 during the course of cuprizone-induced demyelination. In addition, we used TLR2-deficient mice to analyze the functional role of TLR2 activation during cuprizone-induced demyelination and reactive gliosis. We show a significantly increased expression of TLR2 in the corpus callosum and hippocampus of cuprizone-intoxicated mice. The absence of receptor signaling in TLR2-deficient mice resulted in less severe reactive astrogliosis in the corpus callosum and cortex. In addition, microglia activation was ameliorated in the corpus callosum of TLR2-deficient mice, but augmented in the cortex compared to wild-type littermates. Extent of demyelination and loss of mature oligodendrocytes was comparable in both genotypes. These results suggest that the TLR2 orchestrates glia activation during gray and white matter demyelination in the presence of an intact blood-brain barrier. Future studies now have to address the underlying mechanisms of the region-specific TLR2-mediated glia activation.

Entities:  

Keywords:  CNS; Cuprizone; Demyelination; Multiple sclerosis; Pattern recognition receptor; Toll-like receptor

Mesh:

Substances:

Year:  2017        PMID: 29288338     DOI: 10.1007/s12035-017-0838-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  59 in total

1.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

Review 2.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.

Authors:  Bernhard Josef Rüther; Miriam Scheld; Daniela Dreymueller; Tim Clarner; Eugenia Kress; Lars-Ove Brandenburg; Tine Swartenbroekx; Chloé Hoornaert; Peter Ponsaerts; Petra Fallier-Becker; Cordian Beyer; Sven Olaf Rohr; Christoph Schmitz; Uta Chrzanowski; Tanja Hochstrasser; Stella Nyamoya; Markus Kipp
Journal:  Glia       Date:  2017-08-24       Impact factor: 7.452

4.  CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells.

Authors:  Lars-Ove Brandenburg; Sandra Jansen; Lea-Jessica Albrecht; Julika Merres; Joachim Gerber; Thomas Pufe; Simone C Tauber
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

5.  Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

Authors:  T Clarner; A Parabucki; C Beyer; M Kipp
Journal:  J Neuroendocrinol       Date:  2011-07       Impact factor: 3.627

6.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

7.  HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.

Authors:  Yan Sun; Huoying Chen; Jiapei Dai; Huijuan Zou; Ming Gao; Hao Wu; Bingxia Ming; Lin Lai; Yifan Xiao; Ping Xiong; Yong Xu; Feili Gong; Fang Zheng
Journal:  J Neuroimmunol       Date:  2015-02-25       Impact factor: 3.478

8.  Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

Authors:  Asa Andersson; Ruxandra Covacu; Dan Sunnemark; Alexandre I Danilov; Assunta Dal Bianco; Mohsen Khademi; Erik Wallström; Anna Lobell; Lou Brundin; Hans Lassmann; Robert A Harris
Journal:  J Leukoc Biol       Date:  2008-07-21       Impact factor: 4.962

Review 9.  Initial immunopathogenesis of multiple sclerosis: innate immune response.

Authors:  Norma Y Hernández-Pedro; Guillermo Espinosa-Ramirez; Verónica Pérez de la Cruz; Benjamín Pineda; Julio Sotelo
Journal:  Clin Dev Immunol       Date:  2013-09-24

10.  TLR2: an innate immune checkpoint in multiple sclerosis.

Authors:  Md Jakir Hossain; Radu Tanasescu; Bruno Gran
Journal:  Oncotarget       Date:  2015-11-03
View more
  8 in total

1.  Mild myelin disruption elicits early alteration in behavior and proliferation in the subventricular zone.

Authors:  Elizabeth A Gould; Nicolas Busquet; Douglas Shepherd; Robert M Dietz; Paco S Herson; Fabio M Simoes de Souza; Anan Li; Nicholas M George; Diego Restrepo; Wendy B Macklin
Journal:  Elife       Date:  2018-02-13       Impact factor: 8.140

2.  Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes.

Authors:  Georgina Gyetvai; Cieron Roe; Lamia Heikal; Pietro Ghezzi; Manuela Mengozzi
Journal:  Mol Med       Date:  2018-09-27       Impact factor: 6.354

3.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

Review 4.  Microglia Polarization From M1 to M2 in Neurodegenerative Diseases.

Authors:  Shenrui Guo; Hui Wang; Yafu Yin
Journal:  Front Aging Neurosci       Date:  2022-02-16       Impact factor: 5.750

5.  Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.

Authors:  Hao Yang; Lingmin Wu; Huimin Deng; Yuanli Chen; Huanping Zhou; Meiyun Liu; Shaochen Wang; Li Zheng; Lina Zhu; Xin Lv
Journal:  J Neuroinflammation       Date:  2020-05-11       Impact factor: 8.322

Review 6.  Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models.

Authors:  M Elizabeth Deerhake; Debolina D Biswas; William E Barclay; Mari L Shinohara
Journal:  Front Immunol       Date:  2019-11-12       Impact factor: 7.561

7.  Toll-Like Receptor 2 Attenuates Traumatic Brain Injury-Induced Neural Stem Cell Proliferation in Dentate Gyrus of Rats.

Authors:  Xin Zhang; Yue Hei; Wei Bai; Tao Huang; Enming Kang; Huijun Chen; Chuiguang Kong; Yongxiang Yang; Yuqin Ye; Xiaosheng He
Journal:  Neural Plast       Date:  2020-08-17       Impact factor: 3.599

8.  Inhibition of neutral sphingomyelinase 2 promotes remyelination.

Authors:  Seung-Wan Yoo; Amit Agarwal; Matthew D Smith; Saja S Khuder; Emily G Baxi; Ajit G Thomas; Camilo Rojas; Mohammed Moniruzzaman; Barbara S Slusher; Dwight E Bergles; Peter A Calabresi; Norman J Haughey
Journal:  Sci Adv       Date:  2020-10-02       Impact factor: 14.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.